Bio Rad Laboratories Stock Price - BIO

481.15
0.00 (0.0%)
481.15
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Bio Rad Laboratories Inc BIO NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
8.70 1.84% 481.15 475.64 484.71 480.79 472.45 16:01:41
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
6,097 206,048 $ 480.42 $ 98,988,981 243,083 281.66 - 484.71
Last Trade Time Type Quantity Stock Price Currency
16:40:47 formt 1,891 $ 481.15 USD

Bio Rad Laboratories Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 14.27B 29.65M 24.37M $ 2.31B $ 1.57B 58.22 8.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
589.63k $ - 0.00% 2.00 17.60%

more financials information »

Bio Rad Laboratories News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BIO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week473.90484.71460.51468.81182,9437.251.53%
1 Month449.00484.71425.00453.44244,92832.157.16%
3 Months370.32484.71309.3801395.55264,608110.8329.93%
6 Months368.23484.71309.3801384.82236,444112.9230.67%
1 Year294.33484.71281.66358.78215,950186.8263.47%
3 Years218.705484.71208.95303.73177,582262.45120.0%
5 Years144.11484.71122.03259.05155,633337.04233.88%

Bio Rad Laboratories Description

Bio-Rad Laboratories Inc manufactures and supplies systems used to separate and analyze chemical and biological materials to life sciences and healthcare companies. The firm has two business segments: life science and clinical diagnostics. The life sciences segment manufactures reagents and laboratory instruments used by researchers, food producers, and pharmaceutical manufacturers. The clinical diagnostics segment generates over half of the firm's revenue and creates tests systems, informatics systems, test kits, and specialized quality controls for diagnostic labs. It also sells in vitro diagnostic tests to clinical laboratories. Most of the firm's revenue is generated from the United States and Europe.
Your Recent History
NYSE
BIO
Bio Rad La..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200526 21:37:08